JP2014503592A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014503592A5 JP2014503592A5 JP2013551347A JP2013551347A JP2014503592A5 JP 2014503592 A5 JP2014503592 A5 JP 2014503592A5 JP 2013551347 A JP2013551347 A JP 2013551347A JP 2013551347 A JP2013551347 A JP 2013551347A JP 2014503592 A5 JP2014503592 A5 JP 2014503592A5
- Authority
- JP
- Japan
- Prior art keywords
- weight
- migraine
- pharmaceutical preparation
- active ingredient
- treatment
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 208000019695 Migraine disease Diseases 0.000 claims 11
- 206010027599 migraine Diseases 0.000 claims 11
- 239000000825 pharmaceutical preparation Substances 0.000 claims 9
- 239000004480 active ingredient Substances 0.000 claims 8
- SNICXCGAKADSCV-JTQLQIEISA-N (-)-Nicotine Chemical compound CN1CCC[C@H]1C1=CC=CN=C1 SNICXCGAKADSCV-JTQLQIEISA-N 0.000 claims 6
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 claims 6
- 229960002715 nicotine Drugs 0.000 claims 6
- SNICXCGAKADSCV-UHFFFAOYSA-N nicotine Natural products CN1CCCC1C1=CC=CN=C1 SNICXCGAKADSCV-UHFFFAOYSA-N 0.000 claims 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims 5
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims 5
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 claims 4
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 claims 4
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 claims 4
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 claims 4
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 claims 3
- 239000007864 aqueous solution Substances 0.000 claims 3
- 229960001948 caffeine Drugs 0.000 claims 3
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 claims 3
- 235000020776 essential amino acid Nutrition 0.000 claims 2
- 239000003797 essential amino acid Substances 0.000 claims 2
- 239000008194 pharmaceutical composition Substances 0.000 claims 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-UHFFFAOYSA-N Glutamic acid Natural products OC(=O)C(N)CCC(O)=O WHUUTDBJXJRKMK-UHFFFAOYSA-N 0.000 claims 1
- CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims 1
- WHUUTDBJXJRKMK-VKHMYHEASA-N L-glutamic acid Chemical compound OC(=O)[C@@H](N)CCC(O)=O WHUUTDBJXJRKMK-VKHMYHEASA-N 0.000 claims 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 claims 1
- 235000003704 aspartic acid Nutrition 0.000 claims 1
- OQFSQFPPLPISGP-UHFFFAOYSA-N beta-carboxyaspartic acid Natural products OC(=O)C(N)C(C(O)=O)C(O)=O OQFSQFPPLPISGP-UHFFFAOYSA-N 0.000 claims 1
- 235000013922 glutamic acid Nutrition 0.000 claims 1
- 239000004220 glutamic acid Substances 0.000 claims 1
- 229960005190 phenylalanine Drugs 0.000 claims 1
- 235000004400 serine Nutrition 0.000 claims 1
- 229960004799 tryptophan Drugs 0.000 claims 1
- 229960004441 tyrosine Drugs 0.000 claims 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims 1
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201161436370P | 2011-01-26 | 2011-01-26 | |
| US61/436,370 | 2011-01-26 | ||
| PCT/US2012/022788 WO2012103377A1 (en) | 2011-01-26 | 2012-01-26 | Remedy for migraine headache |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2014503592A JP2014503592A (ja) | 2014-02-13 |
| JP2014503592A5 true JP2014503592A5 (enExample) | 2014-05-29 |
Family
ID=46581171
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2013551347A Pending JP2014503592A (ja) | 2011-01-26 | 2012-01-26 | 片頭痛の療法 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US8618118B2 (enExample) |
| EP (1) | EP2667711A4 (enExample) |
| JP (1) | JP2014503592A (enExample) |
| CN (1) | CN103501609A (enExample) |
| AU (1) | AU2012211204B2 (enExample) |
| CA (1) | CA2826019C (enExample) |
| EA (1) | EA201370171A1 (enExample) |
| WO (1) | WO2012103377A1 (enExample) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106511984A (zh) * | 2016-12-02 | 2017-03-22 | 郑州莉迪亚医药科技有限公司 | 一种用于偏头疼的药物及其制备方法 |
| CN106581045A (zh) * | 2016-12-02 | 2017-04-26 | 郑州莉迪亚医药科技有限公司 | 一种治疗偏头疼的药物及其制备方法 |
| KR101982923B1 (ko) * | 2017-07-05 | 2019-05-27 | 가천대학교 산학협력단 | 편두통 진단용 바이오마커 및 상기 바이오마커를 이용한 편두통 진단방법 |
Family Cites Families (24)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9020A (en) * | 1852-06-15 | Improved machine for peaking sheet-metal tubes | ||
| US2018A (en) * | 1841-03-26 | Joseph francis | ||
| US6010A (en) * | 1849-01-09 | Improvement in the manufacture of hats | ||
| IT1179866B (it) | 1984-12-12 | 1987-09-16 | Rotta Research Lab | Derivati del triptofano farmaceuticamente attivi e composizioni farmaceutiche che li contengono |
| US4665069A (en) | 1985-04-02 | 1987-05-12 | Barnett Rosenberg | Analgesic composition and method of relieving pain |
| US4639465A (en) | 1985-08-30 | 1987-01-27 | Commonwealth Medical Corporation Of America | Method and composition for relieving pain |
| SE8701662L (sv) * | 1987-04-22 | 1988-10-23 | Gelder Nico M Van | Saett och medel foer att behandla neurologiska sjukdomar, exempelvis migraen genom paaverkan av nervcellerna |
| US6294520B1 (en) * | 1989-03-27 | 2001-09-25 | Albert T. Naito | Material for passage through the blood-brain barrier |
| US5326569A (en) * | 1992-12-23 | 1994-07-05 | Abbott Laboratories | Medical foods for the nutritional support of child/adult metabolic diseases |
| EP0740935A4 (en) * | 1994-02-24 | 1999-06-16 | Otsuka Pharma Co Ltd | ANALGETIC ACTIVITY AMPLIFIER |
| CA2127573A1 (en) * | 1994-07-07 | 1996-01-08 | Angela Christine Gedye | Vasotonic treatment for migraines |
| GB9617990D0 (en) * | 1996-08-29 | 1996-10-09 | Scotia Holdings Plc | Treatment of pain |
| US6268386B1 (en) | 1998-06-25 | 2001-07-31 | Marshall Anlauf Thompson | Nicotine beverage |
| IT1320776B1 (it) | 2000-08-07 | 2003-12-10 | Giampiero Valletta | Composizione farmaceutica a base di un'associazione vitaminica per laterapia delle cefalee primarie |
| US20060105023A1 (en) * | 2001-12-10 | 2006-05-18 | Knight Joseph R | Treatment of neurological disorders with nicotine |
| CA2479218A1 (en) * | 2002-03-21 | 2003-10-02 | Martin C. Hinz | Serotonin and catecholamine system segment optimization technology |
| ITMI20041689A1 (it) | 2004-09-01 | 2004-12-02 | Bojidar Mihaylov Stankov | Nuove formulazioni di rilascio controllato contenenti 5-idrossitriptofano e triptofano |
| US20070043120A1 (en) | 2005-08-18 | 2007-02-22 | Bettina Beyreuther | Therapeutic combination for painful medical conditions |
| US20070286909A1 (en) * | 2006-06-07 | 2007-12-13 | Daniel S. Smith | Amino acid compositions |
| US20080139510A1 (en) | 2006-12-07 | 2008-06-12 | Abe Rose | Treatment of migraine headaches with sublingual amino acids |
| GB2450076B (en) * | 2007-05-17 | 2012-09-26 | Sis Science In Sport Ltd | Nutritional composition |
| EP2240022B1 (en) * | 2008-01-09 | 2016-12-28 | Charleston Laboratories, Inc. | Bilayered tablets comprising oxycodone and promethazine |
| US20090202635A1 (en) * | 2008-02-08 | 2009-08-13 | Stephen Michael Scott | Delivery System, Application, and Method |
| WO2010112942A1 (en) | 2009-04-02 | 2010-10-07 | Shire Llc | Novel dicarboxylic acid linked amino acid and peptide prodrugs of opioids and uses thereof |
-
2012
- 2012-01-26 EP EP12738959.1A patent/EP2667711A4/en not_active Withdrawn
- 2012-01-26 AU AU2012211204A patent/AU2012211204B2/en not_active Ceased
- 2012-01-26 US US13/359,393 patent/US8618118B2/en not_active Expired - Fee Related
- 2012-01-26 CN CN201280010586.9A patent/CN103501609A/zh active Pending
- 2012-01-26 JP JP2013551347A patent/JP2014503592A/ja active Pending
- 2012-01-26 WO PCT/US2012/022788 patent/WO2012103377A1/en not_active Ceased
- 2012-01-26 EA EA201370171A patent/EA201370171A1/ru unknown
- 2012-01-26 CA CA2826019A patent/CA2826019C/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014218522A5 (enExample) | ||
| JP2011201907A5 (enExample) | ||
| EA201590371A1 (ru) | 1,4-дизамещенные аналоги пиридазина и способы лечения связанных с дефицитом smn состояний | |
| HRP20140011T1 (hr) | Derivati oksazina i njihova uporaba u lijeäśenju neuroloških poremeä†aja | |
| MX2013008296A (es) | Diarilacetileno hidracido que contiene inhibidores de tirosina quinasa. | |
| EA201690541A1 (ru) | Сухой порошковый препарат, содержащий ингибитор фосфодиэстеразы | |
| EA201691242A1 (ru) | Фармацевтические композиции, содержащие azd9291 | |
| EA201490014A1 (ru) | Модифицированное высвобождение 4-метил-3-[[4-(3-пиридинил)-2-пиримидинил]амино]-n-[5-(4-метил-1h-имидазол-1-ил)-3-(трифторметил)фенил]бензамида, солюбилизированного с использованием органических кислот | |
| EA201491674A1 (ru) | Новые фармацевтические композиции | |
| ATE470443T1 (de) | Indol-1-yl-essigsäurederivate | |
| EA201691402A1 (ru) | Фармацевтический препарат, содержащий соединение пиридиламиноуксусной кислоты | |
| JP2012533517A5 (enExample) | ||
| MX2021002253A (es) | Formas cristalinas de 3-(imidazo[1,2-b] piridazin-3- iletinil)-4-metil-n-(4-[(4-metilpiperazin-1-il) metil]-3-(trifluorometil)fenil) benzamida y su sal de monoclorhidrato. | |
| EA201170117A1 (ru) | Противоаллергические биополимеры морского происхождения | |
| FI3666258T3 (fi) | Menetelmä prader-willin oireyhtymän hoitamiseksi | |
| JP2014503592A5 (enExample) | ||
| EA201490840A1 (ru) | Препарат с замедленным высвобождением | |
| TR201001417A1 (tr) | Geliştirilmiş çözünme hızına sahip sefdinir formülasyonu | |
| PH12015502717A1 (en) | Anti-fibrogenic compounds, methods and uses thereof | |
| RU2014115289A (ru) | Композиция пазопаниба | |
| TW200800977A (en) | A new salt | |
| JP2017008001A5 (enExample) | ||
| JP2018528238A5 (enExample) | ||
| FI3263106T3 (fi) | Menetelmä kinoliinijohdannaisen kitkeryyden tukahduttamiseksi | |
| EA201370171A1 (ru) | Лекарство от головной боли при мигрени |